@vittilonghaul
Advanced Stem Cell Exosome Therapy for Long COVID Lung Recovery
At Vitti Labs, we have developed VL-PX10 and VL-P22—an innovative therapy utilizing umbilical cord mesenchymal stem cell exosomes, stem cells, and natural biomaterials. This first-of-its-kind combination targets lung scarring in long-haul COVID-19 patients. We are proud to support healing and recovery with advanced regenerative science.
Website: https://vittilonghaul.com/the-science/
Vitti Long Haul is a trusted tissue bank and life sciences company. We create safe, high-quality products from ethically sourced human birth tissue to help treat many health conditions. Our mission is to provide medical professionals with a full range of birth tissue products and to support them through education and tools that improve patient outcomes and quality of life.
